Anti-Fungal Drugs Market Size Was Valued at USD 15.5 Billion in 2023, and is Projected to Reach USD 21.2 Billion by 2032, Growing at a CAGR of 5.9% From 2024-2032.
The antifungal drugs market refers to medicines that are developed to treat fungal disorders in humans and animals only. These drugs treat such cutaneous disorders as athletes’ foot, and severe invasive systemic disorders like aspergillosis. Its subcategories are drugs both for purchase from the counter and by prescription and formulations oral, topical and injectable for many fungal pathogens and patients.